Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Merck Cervical Cancer Vaccine Approved | Contract Pharma

What are you searching for?

Sign in

Merck Cervical Cancer Vaccine Approved

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck received FDA approval for Gardasil, a vaccine designed to prevent cervical cancer by blocking infection from human papillomavirus (HPV), the most common sexually transmitted disease. The vaccine targets four strains of HPV, two of which are responsible for 70% of cervical cancer cases and another two strains that cause 90% of genital warts.

The FDA approved Gardasil for females ages 9 through 26, with the goal of inoculating girls before they may become sexually active. About half a million women are diagnosed with cervical cancer each year. Gardasil shots will be given in three doses over six months, with each dose costing $120, according to Merck.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters